- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 21-08-2026: Press Release
21-08-2026 | 01:52 pm
21-08-2026 | 01:52 pm
Zydus secured US approval for generic Ascorbic Acid Injection, gaining 180-day market exclusivity. This product, with annual brand sales of USD 11.6 mn, will be manufactured in Gujarat for the US market.
No comments yet. Be the first to comment!